Published

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: BMJ open
Date: 2023-05-04
Source: PubMed
DOI: 10.1136/bmjopen-2022-068884
PubMed: 37142308

Authors

Davis AK Levin AW Nagib PB Armstrong SB Lancelotta RL

Watch author

Derived topics and classifications

psilocybin Anxiety PTSD Pharmacology Clinical Trial Review Article Veterans Healthcare Workers Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.2023-05-04

Related papers

Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10 Psilocybin as a Treatment for Chronic Pain in SmokersClinicalTrials.gov · 2026-08-03 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23